MustGrow Biologics Corp.
MGROF
$0.6588
-$0.0576-8.04%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.67M | 3.46M | 3.46M | 3.46M | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.67M | 3.46M | 3.46M | 3.46M | 0.00 |
| Cost of Revenue | 187.60K | 178.00K | 282.90K | 285.40K | 229.50K |
| Gross Profit | 3.48M | 3.29M | 3.18M | 3.18M | -229.50K |
| SG&A Expenses | 2.82M | 2.71M | 2.72M | 2.73M | 2.75M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.53M | 3.41M | 3.61M | 3.65M | 3.55M |
| Operating Income | 133.80K | 49.90K | -144.30K | -187.60K | -3.55M |
| Income Before Tax | -179.80K | -334.00K | -526.50K | -532.90K | -3.79M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.18 | -0.33 | -0.53 | -0.53 | -3.79 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -179.80K | -334.00K | -526.50K | -532.90K | -3.79M |
| EBIT | 133.80K | 49.90K | -144.30K | -187.60K | -3.55M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | -0.01 | -0.01 | -0.01 | -0.08 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.05 |
| EPS Diluted | 0.00 | -0.01 | -0.01 | -0.01 | -0.08 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.05 |
| Average Basic Shares Outstanding | 205.07M | 203.31M | 201.36M | 199.58M | 198.92M |
| Average Diluted Shares Outstanding | 205.07M | 203.31M | 201.36M | 199.58M | 198.92M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
